Medical device startup, Love Lifesciences, has closed a $1 million pre-seed fundraising round from ‘local angel investors and the GROWKS investment fund.’
Nick Love, Love Lifesciences CEO
“We received $600,000 in financial cash commitments as well as $400,000 in future commitments,” CEO Nick Love told bizblip. The money is earmarked for manufacturing and scaling its two existing products, more R&D, better securing IP, as well as developing a third product that is still ‘under wraps.’
The startup is developing a series of safety injection devices to prevent needle-stick and dosing error, as well as an improved injection experience for those self administering medications. In 2022 Love and co-founder CTO Bradley Hopper completed the research and development phase on a single use device and are starting FDA testing.
Love Lifesciences landed a $25,000 grant from the Kansas Department of Commerce’s KITE Proof of Concept program as well as $20,000 from Digital Sandbox, both in 2021. The startup also raised $124,ooo from 24 investors over WeFunder in Nov. 2022.
The Olathe, KS company launched in October of 2020. Side note: Nick Love just graduated from medical school.
